World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
Shomali W, Gotlib J.
Am J Hematol. 2024 May;99(5):946-968. doi: 10.1002/ajh.27287. Epub 2024 Mar 29.
B-acute lymphoblastic leukemia with eosinophilic inclusions.
Helman SR, Singh ZN.
Blood. 2023 Mar 30;141(13):1645. doi: 10.1182/blood.2022018796.
Uncommon phenotypes of acute myelogenous leukemia: basophilic, mast cell, eosinophilic, and myeloid dendritic cell subtypes: a review.
Lichtman MA, Segel GB.
Blood Cells Mol Dis. 2005 Nov-Dec;35(3):370-83. doi: 10.1016/j.bcmd.2005.08.006. Epub 2005 Oct 3.
Acute Leukemia in Horses.
Cooper CJ, Keller SM, Arroyo LG, Hewson J, Kenney D, Bienzle D.
Vet Pathol. 2018 Jan;55(1):159-172. doi: 10.1177/0300985817720983. Epub 2017 Aug 16.
World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management.
Shomali W, Gotlib J.
Am J Hematol. 2022 Jan 1;97(1):129-148. doi: 10.1002/ajh.26352. Epub 2021 Oct 8.
Acute myelogenous leukemia with eosinophilic differentiation and trisomy-1.
Harrington DS, Peterson C, Ness M, Sanger W, Smith DM, Vaughan W.
Am J Clin Pathol. 1988 Oct;90(4):464-9. doi: 10.1093/ajcp/90.4.464.
Eosinophilic folliculitis occurring after stem cell transplant for acute lymphoblastic leukemia: a case report and review.
Zitelli K, Fernandes N, Adams BB.
Int J Dermatol. 2015 Jul;54(7):785-9. doi: 10.1111/ijd.12521. Epub 2014 Jul 11.
GPNMB expression identifies TSC1/2/mTOR-associated and MiT family translocation-driven renal neoplasms.
Salles DC, Asrani K, Woo J, Vidotto T, Liu HB, Vidal I, Matoso A, Netto GJ, Argani P, Lotan TL.
J Pathol. 2022 Jun;257(2):158-171. doi: 10.1002/path.5875. Epub 2022 Mar 29.
[Acute eosinophilic leukemia].
Koza V.
Vnitr Lek. 1989 Oct;35(10):1039-40.
[Acute eosinophilic leukemia].
RINGELHANN B, HALLAY I.
Orv Hetil. 1955 Nov 6;96(45):1253-7.
